Modified Rankin Scale (mRS)
Select the grade that best describes the patient's level of disability.
Yksityiskohtainen opas tulossa pian
Työskentelemme kattavan oppaan parissa kohteelle Modified Rankin Scale (mRS). Palaa pian katsomaan vaiheittaiset selitykset, kaavat, käytännön esimerkit ja asiantuntijavinkit.
The Modified Rankin Scale (mRS) is a widely used clinician-reported scale that quantifies the degree of disability and dependence in daily activities following a stroke or other neurological event. Originally developed by John Rankin in 1957 and subsequently modified to its current form, the mRS is the primary functional outcome measure used in virtually all major stroke trials worldwide. It is a simple ordinal scale with seven levels ranging from 0 (no symptoms at all) to 6 (death). Grade 0 represents complete normality; Grade 1 indicates no significant disability despite some symptoms — the patient can carry out all usual duties and activities; Grade 2 represents slight disability where the patient cannot carry out all previous activities but can look after their own affairs without assistance; Grade 3 reflects moderate disability requiring some help but able to walk without assistance; Grade 4 represents moderately severe disability where the patient cannot walk without assistance and cannot attend to their own bodily needs without assistance; Grade 5 indicates severe disability where the patient is bedridden, incontinent, and requires constant nursing care; and Grade 6 is death. The mRS is used to assess outcome at 90 days after stroke onset, which is the standard endpoint in acute stroke trials. A score of 0-2 at 90 days is widely accepted as a favourable functional outcome. The scale's simplicity makes it reproducible across different clinical settings and languages, though its apparent simplicity conceals important inter-rater variability that has led to the development of structured and video-based training programs.
Modified Rankin Scale: 0=No symptoms; 1=No significant disability (all usual duties); 2=Slight disability (looks after own affairs, needs some help); 3=Moderate disability (requires help, walks unaided); 4=Moderately severe (cannot walk or tend to bodily needs without help); 5=Severe disability (bedridden, incontinent, constant care); 6=Dead; No arithmetic — clinical pattern match
- 1Conduct a structured interview with the patient (and carer if appropriate), asking specifically about current ability to perform usual activities and any residual symptoms.
- 2Begin at Grade 0 and work upward: confirm whether the patient has any symptoms at all — if none, assign Grade 0.
- 3If symptoms are present, assess whether the patient can perform all previous work and social activities — if yes and symptoms are mild, assign Grade 1.
- 4If the patient cannot perform all previous activities but can manage all personal care without help, assign Grade 2.
- 5If the patient requires some help from others but can still walk without physical assistance, assign Grade 3.
- 6If the patient cannot walk unaided or tends to bodily needs without assistance, but does not require round-the-clock care, assign Grade 4.
- 7If the patient is bedridden, incontinent, and dependent on others for all care, assign Grade 5; Grade 6 is assigned if the patient has died.
Considered excellent outcome in stroke trials; classified as favourable outcome
Despite residual aphasia, the patient meets all usual activities criteria and requires no assistance. This is the benchmark for minimal stroke impact.
Favourable outcome threshold — important distinction from mRS 3
This patient has given up some previous activities but manages all personal affairs independently. The mRS 0-2 threshold for favourable outcome in trials hinges on this independent function.
Unfavourable outcome; consider rehabilitation goals and carer support
The distinction between mRS 3 (walks unaided) and mRS 4 (cannot walk unaided) is critical and is the most commonly debated boundary in the scale.
High care needs; nursing home placement often required
Grade 5 represents the highest disability short of death. These patients require round-the-clock care and have very poor quality of life. Palliative care discussions may be appropriate.
Primary endpoint in all major acute stroke treatment trials including thrombolysis and mechanical thrombectomy studies., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization
Routine discharge assessment after stroke to document functional level and guide rehabilitation goals and discharge destination., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization
National audit data collection — UK Sentinel Stroke National Audit Programme (SSNAP) records mRS at discharge and 6 months for all stroke admissions., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization
Informing family members and carers about the patient's likely long-term level of independence after stroke., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization
Health economic analyses calculating quality-adjusted life years (QALYs) by mapping mRS levels to utility weights., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization
Pre-existing Disability
In the Rankin Scale, this scenario requires additional caution when interpreting rankin scale results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rankin scale calculations fall into non-standard territory.
Certain complex rankin scale scenarios may require additional parameters beyond the standard Rankin Scale inputs.
These might include environmental factors, time-dependent variables, regulatory constraints, or domain-specific rankin scale adjustments materially affecting the result. When working on specialized rankin scale applications, consult industry guidelines or domain experts to determine whether supplementary inputs are needed. The standard calculator provides an excellent starting point, but specialized use cases may require extended modeling approaches.
Early vs 90-Day Assessment
In the Rankin Scale, this scenario requires additional caution when interpreting rankin scale results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rankin scale calculations fall into non-standard territory.
Excellent Neurological Recovery with Social Limitations
In the Rankin Scale, this scenario requires additional caution when interpreting rankin scale results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rankin scale calculations fall into non-standard territory.
| Grade | Description | Independence Level | Trial Classification |
|---|---|---|---|
| 0 | No symptoms | Fully independent | Favourable |
| 1 | No significant disability | All usual activities | Favourable |
| 2 | Slight disability | Independent, some activities limited | Favourable |
| 3 | Moderate disability | Needs help, walks unaided | Unfavourable |
| 4 | Moderately severe | Needs help walking and personal care | Unfavourable |
| 5 | Severe disability | Bedridden, incontinent, constant care | Unfavourable |
| 6 | Dead | — | Unfavourable |
What is the modified Rankin Scale used for in stroke?
The mRS is the primary functional outcome measure in acute stroke trials. A score of 0-2 at 90 days after stroke onset is the standard definition of a favourable (good) functional outcome. It is used to compare treatment arms in randomised controlled trials. This is particularly important in the context of rankin scale calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rankin scale computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
What is the difference between mRS 0 and mRS 1?
mRS 0 means the patient has absolutely no symptoms whatsoever. mRS 1 means the patient has some symptoms (such as mild weakness or speech difficulty) but these symptoms do not prevent them from performing any of their usual duties or activities. This is particularly important in the context of rankin scale calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rankin scale computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
What distinguishes mRS 2 from mRS 3?
The key distinction is whether the patient needs help from another person for daily activities. mRS 2 patients cannot do everything they used to do but do not require help from others. mRS 3 patients require some help from another person but can still walk without physical assistance. This is particularly important in the context of rankin scale calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rankin scale computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
How is the mRS scored reliably across different assessors?
Inter-rater variability is a known limitation of the mRS. Structured interviews, videos showing typical patients at each level, and web-based training programmes (such as those from NINDS) significantly improve reliability. Certification training is recommended for clinical trial assessors. This is particularly important in the context of rankin scale calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rankin scale computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Is the mRS the same as the Barthel Index?
No. The mRS is a global assessment of disability and social dependence, while the Barthel Index assesses ten specific activities of daily living with numeric scoring. They measure complementary aspects of function and are often used together in stroke research. This is particularly important in the context of rankin scale calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rankin scale computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
What pre-stroke mRS should be used in research?
Most stroke trials report both pre-stroke mRS (baseline) and 90-day mRS. Patients with pre-stroke mRS ≥2-3 are often excluded from trials or analysed separately. The shift analysis compares the entire distribution of mRS scores between treatment groups. This is particularly important in the context of rankin scale calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rankin scale computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Can the mRS be assessed remotely or by telephone?
Telephone-based mRS assessment using a structured interview has been validated and is widely used in clinical trials when in-person assessment is not possible. Structured versions with standardised questions achieve comparable reliability to in-person assessment. This is particularly important in the context of rankin scale calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rankin scale computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Why is mRS 0-2 rather than mRS 0-1 used as the favourable outcome threshold?
mRS 0-2 was chosen because mRS 2 patients remain independent in personal care and do not require help from others, representing a level of function compatible with independent living even if some previous activities are curtailed. Including mRS 3 would include patients requiring daily assistance, which is generally considered an unfavourable outcome.
Ammattilaisen vinkki
Use the structured mRS interview format rather than free questioning. Ask explicitly: 'Do you need help from another person to do any of your daily activities?' The answer to this single question most reliably distinguishes mRS 2 from mRS 3, which is the most clinically consequential boundary.
Tiesitkö?
The Rankin Scale was originally published by John Rankin in the Edinburgh Medical Journal in 1957, predating CT scanning by nearly two decades. The scale was modified to its current five-grade form (plus death) in 1988 by van Swieten and colleagues. Despite being over 65 years old, it remains the most widely used outcome measure in stroke medicine worldwide.
Viitteet
- ›Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957.
- ›van Swieten JC et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988.
- ›Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale. Stroke 2007.
- ›Saver JL et al. Clinical utility of a brief instructional video before modified Rankin Scale assessment. Stroke 2010.
Hanki viikoittaisia matematiikkavinkkejä
Liity 12 000+ tilaajien joukkoon, jotka saavat laskurivinkkejä joka viikko.